Glomerulosclerosis markers for chronic glomerular diseases and detection kits of glomerulosclerosis markers
A technology for glomerular diseases and glomerulosclerosis, applied in the medical field, can solve problems such as unclear pathogenesis, complicated etiology, and high biological markers
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment
[0020] The embodiment of the present invention provides a chronic glomerular disease glomerulosclerosis marker, the marker is miRNA-196a, miRNA-155, miRNA-490 and interleukin in urine.
[0021] The method of extracting miRNA-196a, miRNA-155, and miRNA-490 from urine is as follows: take an appropriate amount of urine supernatant and add twice the volume of Trizol reagent, and then perform 2 times of phenol / chloroform extraction, and the obtained RNA is dissolved in 20 μl DEPC water Using microRNA low-density chip detection, take 300 μl sample and add 100 μl DEPC water, mix well, add an equal volume of acidic phenol and chloroform for extraction, and obtain miRNA-196a, miRNA-155, miRNA-490, and then RNA is dissolved in 10 μl DEPC water, Store at -80°C, the pH of acidic phenol is 5.0-5.5, and the volume ratio of acidic phenol to chloroform is 1:1.
[0022] The method of extracting interleukin from urine is as follows: take an appropriate amount of urine and dilute it, add 1 / 4 of ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com